Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Biomedical Research Foundation

Neither a doctor nor a teaching hospital

Research payments

$613,872

136 payments

Through program year 2025, Biomedical Research Foundation is reported as receiving $613,872 in research payments, across 136 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $18,019 2
2024 Research $54,680 5
2023 Research $123,107 17
2022 Research $25,864 15
2021 Research $68,458 29
2020 Research $81,139 29
2019 Research $242,607 39

Breakdown

Who paid Research payments · program years 2019–2025
  1. LivaNova USA, Inc. $201,211 46 payments
  2. CathWorks, Inc. $94,219 5 payments
  3. Amgen Inc. $65,241 5 payments
  4. Fresenius USA Marketing, Inc. $54,947 6 payments
  5. CSL Behring $33,766 19 payments
  6. Sanofi US Services Inc. $23,246 4 payments
  7. TriReme Medical LLC $22,350 4 payments
  8. Zimmer Biomet Holdings, Inc. $19,682 10 payments
  9. W. L. Gore & Associates, Inc. $18,500 1 payment
  10. Alexion Pharmaceuticals, Inc. $17,797 7 payments
Studies the money was for Research payments · program years 2019–2025
  1. ANTHEM HFrEF $201,211 46 payments
  2. All-Rise $94,219 5 payments
  3. Safety of Regional Citrate Anticoagulation (SARCA Study) (SARCA) $48,198 5 payments
  4. Galactic-Hf $38,483 2 payments
  5. Balloon Catheter $22,350 4 payments
  6. A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome $18,766 15 payments
  7. A Comparison of the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX) to Bare Mental Stenting for Patients with Complex Iliac Occlusive Disease $18,500 1 payment
  8. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared With Best Supportive Care in Patients With COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome $17,797 7 payments
  9. MarrOwStim PAD Kit for the Treatment of Critical LimB IschemIa CLI in Subjects with Severe Peripheral ArteriaL DiseasE PAD MOBILE $17,339 5 payments
  10. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients With Type 2 Diabetes POST Worsening Heart Failure $16,000 2 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $5,891 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record